Literature DB >> 3225607

Familial autoimmune myasthenia gravis with different pathogenetic antibodies.

C Provenzano1, O Arancio, A Evoli, B Rocca, E Bartoccioni, D de Grandis, P Tonali.   

Abstract

Two cases of familial myasthenia gravis are reported. One patient is a typical case of autoimmune myasthenia with positive anti acetylcholine receptor antibodies, while in the second patient the impairment of neuromuscular transmission is likely to be due to antibodies directed against determinants other than the acetylcholine receptors.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3225607      PMCID： PMC1033034          DOI： 10.1136/jnnp.51.9.1228

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  10 in total

1.  Immunological heterogeneity and cellular mechanisms in myasthenia gravis.

Authors:  J Newsom-Davis; N Willcox; M Schluep; G Harcourt; A Vincent; S Mossman; D Wray; J Burges
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

2.  Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families.

Authors:  T Namba; N G Brunner; S B Brown; M Muguruma; D Grob
Journal:  Arch Neurol       Date:  1971-07

3.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.

Authors:  D A Compston; A Vincent; J Newsom-Davis; J R Batchelor
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

4.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

5.  Anti-acetylcholine receptor antibodies.

Authors:  A Vincent; J Newsom Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

Review 6.  Myasthenia gravis and myasthenic syndromes.

Authors:  A G Engel
Journal:  Ann Neurol       Date:  1984-11       Impact factor: 10.422

7.  Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.

Authors:  U A Besinger; K V Toyka; M Hömberg; K Heininger; R Hohlfeld; A Fateh-Moghadam
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

8.  Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.

Authors:  E Bartoccioni; F Scuderi; C Scoppetta; A Evoli; P Tonali; L Guidi; C Bartoloni; T Terranova
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

9.  Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.

Authors:  S Mossman; A Vincent; J Newsom-Davis
Journal:  Lancet       Date:  1986-01-18       Impact factor: 79.321

10.  An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.

Authors:  J Lindstrom
Journal:  Clin Immunol Immunopathol       Date:  1977-01
  10 in total
  4 in total

1.  A retrospective review of 15 patients with familial myasthenia gravis over a period of 25 years.

Authors:  Hui-Yu Feng; Wei-Bin Liu; Chuan-Ming Luo; Li-Xuan Yang; Wei Fang; Li Qiu; Xin Huang; Yan Li; Ru-Xun Huang
Journal:  Neurol Sci       Date:  2011-11-05       Impact factor: 3.307

2.  Whole-exome sequencing reveals a rare interferon gamma receptor 1 mutation associated with myasthenia gravis.

Authors:  Guoyan Qi; Peng Liu; Shanshan Gu; Hongxia Yang; Huimin Dong; Yinping Xue
Journal:  Neurol Sci       Date:  2018-02-13       Impact factor: 3.307

3.  The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population.

Authors:  Hui-Yu Feng; Li-Xuan Yang; Wei-Bin Liu; Xin Huang; Li Qiu; Yan Li
Journal:  Neurol Sci       Date:  2015-05-08       Impact factor: 3.307

4.  Familial autoimmune myasthenia gravis: report of four families.

Authors:  A Evoli; A P Batocchi; G Zelano; A Uncini; M T Palmisani; P Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.